Sinclair’s Life Biosciences Secures $80M for Groundbreaking Epigenetic Trial
Sinclair’s groundbreaking $80 million funding signals a pivot toward epigenetic therapies as the future of age-related treatment.
gene therapy
Sinclair’s Life Biosciences Secures $80M to Pioneer Gene Therapy Trials
Sinclair’s Life Biosciences secures $80M, highlighting a significant shift in innovative longevity therapies and gene therapy.
5 Breakthroughs That Could Eradicate Autoimmune Diseases in Our Lifetime
Explore groundbreaking developments in gene therapy and AI, poised to transform autoimmune disease treatment.
5 Breakthroughs That Could Eradicate Autoimmune Diseases in Our Lifetime
Explore groundbreaking developments in gene therapy and AI, poised to transform autoimmune disease treatment.
5 Breakthroughs That Could Revolutionize Autoimmune Disease Treatments
Explore transformative breakthroughs in autoimmune disease treatments, from gene therapy to AI-driven solutions.